Trial Profile
The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2014
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 19 Sep 2014 New trial record